Effect of human growth hormone treatment on the organ of vision of patients with somatotropic pituitary insufficiency and girls with Turner's syndrome;Ocena wpływu terapii ludzkim hormonem wzrostu na narza̧d wzroku pacjentów z somatotropinowa̧ niedoczynnościa̧ przysadki i pacjentek z zespołem Turnera

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 11, Issue 1, 2005, Pages 9-12

  Urban, Beata ^a   Gardziejczyk, Maria ^b   Urban, Mirosława ^b   Bakunowicz Łazarczyk, Alina ^a  

^a AM ^*  (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Contrast sensitivity; Human growth hormone therapy; Retinal changes

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BRAIN PSEUDOTUMOR; CLINICAL ARTICLE; CONTRAST SENSITIVITY; DRUG SAFETY; DRUG USE; EVALUATION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; OPHTHALMOLOGY; OPHTHALMOSCOPY; PAPILLEDEMA; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RETINAL CHANGES; SCHOOL CHILD; TURNER SYNDROME;

ADOLESCENT; CHILD; EYE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; OPTIC NERVE; RETINA; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 18844436183     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. rd, Rizza R.A: The role of growth hormone in development of diabetic retinopathy. Diabetes Care, 1994, 17, 531.
2. Blank D., Riedl M., Reitner A. i wsp.: Growth hormone replacement therapy is not associated with retinal changes. J. Clin. Endocrinol. Metab., 2000, 85, 634.
3. Blethen S.L.: Complications of growth hormone therapy in children. Curr. Opin. Pediatr, 1995, 7, 466.
4. Bodalski J., Mianowska B.: Wpływ leczenia rekombinowanym ludzkim hormonem wzrostu na metabolizm glukozy. Endokrynol. Diabetol. Choroby Przemiany Materii Wieku Rozw., 1998, 4, 61.
5. Crock P.A., McKenzie J.D., Nicoll A.M. i wsp.: Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatr., 1998, 87, 381.
6. Hellström A., Svensson E., Carlsson B. i wsp.: Reduced retinal vascularization in children with growth hormone deficiency. J. Clin. Endocrinol. Metab., 1999, 84, 795.
7. Johansson J.O., Larson G., Andersson M. i wsp.: Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology, 1995, 61, 57.
8. Koller E.A., Green L., Gertner J.M.: Retinal changes mimicking diabetic retinopathyin two nondiabetic, growth hormone-treated patients. J. Clin. Endocrinol. Metab., 1998, 83, 2380.
9. Koller E.A., Stadel B.V., Malozowski S.N.: Papilloedema in 15 renally compromised patients treated with growth hormone. Pediatr. Nephrol., 1997, 11, 451.
10. Lessel S.: Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv. Ophthalmol., 1992, 37, 155.
11. Malozowski S., Tanner L.A., Wysowski D.K. i wsp.: Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J. Pediatr., 1995, 126, 996.
12. Rogers A.M., Rogers G.L., Bremer D.L., McGregor M.L.: Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology, 1999, 106, 1186.
13. Rymaszewski Z., Cohen R.M., Chomczynski P.: Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro. Proc. Natl. Acad. Sci. USA, 1991, 88, 617.
14. Smith L.E., Kopchick J.J., Chen W. i wsp.: Essential role of growth hormone in ischemia-induced retinal neovascularization. Science, 1997, 276, 1706.